How to buy AxoGen stock - 13 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy AxoGen stock

Own AxoGen stock in just a few minutes.

AxoGen, Inc is a medical devices business based in the US. AxoGen shares (AXGN) are listed on the NASDAQ and all prices are listed in US Dollars. AxoGen employs 346 staff and has a trailing 12-month revenue of around USD$112.3 million.

How to buy shares in AxoGen

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for AxoGen. Find the stock by name or ticker symbol: AXGN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AxoGen reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of AxoGen, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of AxoGen. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

AxoGen share price

Use our graph to track the performance of AXGN stocks over time.

AxoGen shares at a glance

Information last updated 2021-04-07.
52-week rangeUSD$7.16 - USD$22.89
50-day moving average USD$20.5043
200-day moving average USD$16.9129
Wall St. target priceUSD$23.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.666

Buy AxoGen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AxoGen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AxoGen financials

Revenue TTM USD$112.3 million
Gross profit TTM USD$90.7 million
Return on assets TTM -8.14%
Return on equity TTM -18.63%
Profit margin -21.18%
Book value $3.032
Market capitalisation USD$785.7 million

TTM: trailing 12 months

Shorting AxoGen shares

There are currently 829,155 AxoGen shares held short by investors – that's known as AxoGen's "short interest". This figure is 6% up from 782,324 last month.

There are a few different ways that this level of interest in shorting AxoGen shares can be evaluated.

AxoGen's "short interest ratio" (SIR)

AxoGen's "short interest ratio" (SIR) is the quantity of AxoGen shares currently shorted divided by the average quantity of AxoGen shares traded daily (recently around 315268.0608365). AxoGen's SIR currently stands at 2.63. In other words for every 100,000 AxoGen shares traded daily on the market, roughly 2630 shares are currently held short.

However AxoGen's short interest can also be evaluated against the total number of AxoGen shares, or, against the total number of tradable AxoGen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AxoGen's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 AxoGen shares in existence, roughly 20 shares are currently held short) or 0.0252% of the tradable shares (for every 100,000 tradable AxoGen shares, roughly 25 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AxoGen.

Find out more about how you can short AxoGen stock.

AxoGen share dividends

We're not expecting AxoGen to pay a dividend over the next 12 months.

Have AxoGen's shares ever split?

AxoGen's shares were split on a 105:100 basis on 10 July 1994. So if you had owned 100 shares the day before before the split, the next day you'd have owned 105 shares. This wouldn't directly have changed the overall worth of your AxoGen shares – just the quantity. However, indirectly, the new 4.8% lower share price could have impacted the market appetite for AxoGen shares which in turn could have impacted AxoGen's share price.

AxoGen share price volatility

Over the last 12 months, AxoGen's shares have ranged in value from as little as $7.16 up to $22.89. A popular way to gauge a stock's volatility is its "beta".

AXGN.US volatility(beta: 0.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AxoGen's is 0.7303. This would suggest that AxoGen's shares are less volatile than average (for this exchange).

AxoGen overview

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site